Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525 
 
Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525 
  
 
Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530 
     free
  
Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531 
     free
      free
  
Warning:  file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=19074824&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
 in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445 
   English Wikipedia
  Nephropedia Template TP (
  Twit Text
 
  DeepDyve Pubget Overpricing |    
 
  lüll Eicosanoid signalling pathways in the heart Jenkins CM; Cedars A; Gross RWCardiovasc Res  2009[May]; 82 (2): 240-9Myocardial phospholipids serve as primary reservoirs of arachidonic acid (AA),  which is liberated through the rate-determining hydrolytic action of cardiac  phospholipases A2 (PLA2s). A predominant PLA2 in myocardium is  calcium-independent phospholipase A2beta (iPLA2beta), which, through its  calmodulin (CaM) and ATP-binding domains, is regulated by alterations in local  cellular Ca2+ concentrations and cardiac bioenergetic status, respectively.  Importantly, iPLA2beta has been demonstrated to be activated by ischaemia through  elevation of the concentration of myocardial fatty acyl-CoA, which abrogates  Ca2+/CaM-mediated inhibition of iPLA2beta. AA released by PLA2-catalysed  hydrolysis of phospholipids serves as a precursor for eicosanoids generated by  pathways dependent on cyclooxygenases (COX), lipoxygenases (LOX), and cytochromes  P450 (CYP). Eicosanoids initiate and propagate diverse signalling cascades,  primarily through their interaction with cellular receptors and ion channels.  However, during pathologic states such as ischaemia or congestive heart failure,  eicosanoids contribute to multiple maladaptive changes including inflammation,  alterations of cellular growth programmes, and activation of multiple  transcriptional events leading to the deleterious sequelae of these pathologic  states. This review summarizes the central roles of myocardial PLA(2)s in  eicosanoid signalling in the heart, the major COX, LOX, and CYP pathways of  eicosanoid generation in the myocardium, and the effects of important eicosanoids  on receptor-, ion channel-, and transcription-mediated processes that facilitate  cardiac hypertrophy, mediate ischaemic preconditioning, and precipitate  arrhythmogenesis in response to pathologic stimuli.|Animals[MESH]|Cytochrome P-450 Enzyme System/physiology[MESH]|Eicosanoids/*physiology[MESH]|Heart/*physiology[MESH]|Humans[MESH]|Lipoxygenase/physiology[MESH]|Mice[MESH]|Models, Animal[MESH]|Phospholipases A2/physiology[MESH]|Prostaglandin-Endoperoxide Synthases/physiology[MESH]|Rats[MESH]|Signal Transduction/*physiology[MESH] |